Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 7—July 2008

Testing for Coccidioidomycosis among Patients with Community-Acquired Pneumonia

Douglas C. Chang*Comments to Author , Shoana Anderson†, Kathleen Wannemuehler*, David M. Engelthaler†, Laura Erhart†, Rebecca H. Sunenshine†, Lauren A. Burwell*, and Benjamin J. Park*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Arizona Department of Health Services, Phoenix, Arizona, USA;

Main Article

Table 3

Characteristics of patients with community-acquired pneumonia (CAP) who were tested for coccidioidomycosis, Maricopa County, Arizona, January 2003–December 2004*

Characteristic Case-patients, no. (%), n = 60 Controls, no. (%), n = 76 Odds ratio (95% CI) Adjusted odds ratio† (95% CI)
Age >18 y 53 (88) 44 (58) 5.5 (2.1–15.3)‡ 5.3 (1.5–24.0)
Male 28 (55) 40 (53) 0.9 (0.5–1.9) NS
Chest pain 19 (32) 7 (9) 4.6 (1.8–11.8)‡ 3.9 (1.2–13.8)
Rash 5 (8) 0 Undefined (1.2–Undefined)‡ 21.1§ (2.2–undefined)
Diabetes mellitus or immunosuppressive condition 10 (17) 4 (5) 3.6 (1.0–16.5)‡ NS
Symptoms >14 d 20 (33) 6 (8) 5.8 (2.1–15.7)‡ 4.1 (1.3–14.2)

*CI, confidence interval; NS, not significant. Case-patients were patients who had CAP and had received Coccidioides spp. serologic testing, regardless of test result; controls were patients who had CAP but had not received Coccidioides spp. serologic testing.
†Adjusted odds ratios and exact 95%CI from a multivariable logistic regression model.
‡Significant (p<0.05) according to univariate analysis.
§Median unbiased estimate of the adjusted odds ratio.

Main Article

Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.